Objective: To evaluate how breast cancers are depicted by artificial intelligence–based computer-assisted diagnosis (AI-CAD) according to clinical, radiological, and pathological factors. Materials and methods: From January 2017 to December 2017, 896 patients diagnosed with 930 breast cancers were enrolled in this retrospective study. Commercial AI-CAD was applied to digital mammograms and abnormality scores were obtained. We evaluated the abnormality score according to clinical, radiological, and pathological characteristics. False-negative results were defined by abnormality scores less than 10. Results: The median abnormality score of 930 breasts was 87.4 (range 0–99). The false-negative rate of AI-CAD was 19.4% (180/930). Cancers with an abnormality score of more than 90 showed a high proportion of palpable lesions, BI-RADS 4c and 5 lesions, cancers presenting as mass with or without microcalcifications and invasive cancers compared with low-scored cancers (all p < 0.001). False-negative cancers were more likely to develop in asymptomatic patients and extremely dense breasts and to be diagnosed as occult breast cancers and DCIS compared to detected cancers. Conclusion: Breast cancers depicted with high abnormality scores by AI-CAD are associated with higher BI-RADS category, invasive pathology, and higher cancer stage. Key Points: • High-scored cancers by AI-CAD included a high proportion of BI-RADS 4c and 5 lesions, masses with or without microcalcifications, and cancers with invasive pathology. • Among invasive cancers, cancers with higher T and N stage and HER2-enriched subtype were depicted with higher abnormality scores by AI-CAD. • Cancers missed by AI-CAD tended to be in asymptomatic patients and extremely dense breasts and to be diagnosed as occult breast cancers by radiologists.
Bibliographical notePublisher Copyright:
© 2022, The Author(s), under exclusive licence to European Society of Radiology.
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging